(Q37972352)

26 August 2017

External insulin pump treatment in the day-to-day management of diabetes: benefits and future prospectives (English)

1 reference

26 August 2017

H Hanaire

1

1 reference

26 August 2017

1 December 2011

1 reference

26 August 2017

Diabetes and Metabolism

1 reference

26 August 2017

37 Suppl 4

1 reference

26 August 2017

S40-7

1 reference

Continuous subcutaneous insulin infusion: an approach to achieving normoglycaemia

26 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970964-8

7 January 2021

Treatment of diabetes mellitus using an external insulin pump: the state of the art.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970964-8

7 January 2021

Long-term safety, efficacy and side-effects of continuous subcutaneous insulin infusion treatment for type 1 (insulin-dependent) diabetes mellitus: a one centre experience

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970964-8

7 January 2021

A crossover comparison of continuous insulin infusion and conventional injection treatment of type I diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970964-8

7 January 2021

Clinical use of the insulin infusion pump in 100 patients with type I diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970964-8

7 January 2021

Evaluation of insulin pump treatment under routine conditions

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970964-8

7 January 2021

Implementation of treatment protocols in the Diabetes Control and Complications Trial

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970964-8

7 January 2021

Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomised controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970964-8

7 January 2021

Insulin pump therapy: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970964-8

7 January 2021

Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970964-8

7 January 2021

Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens using insulin lispro in type 1 diabetic patients on intensified treatment: a randomized study. The Study Group for the Development of Pump Therapy in Diabet

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970964-8

7 January 2021

Improvement of HbA1c and blood glucose stability in IDDM patients treated with lispro insulin analog in external pumps.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970964-8

7 January 2021

Use of insulin lispro in continuous subcutaneous insulin infusion treatment. Results of a multicenter trial. German Humalog-CSII Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970964-8

7 January 2021

Are analogue insulins better than soluble in continuous subcutaneous insulin infusion? Results of a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970964-8

7 January 2021

A randomized trial of continuous subcutaneous insulin infusion and intensive injection therapy in type 1 diabetes for patients with long-standing poor glycemic control

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970964-8

7 January 2021

Intensive insulin therapy with insulin lispro: a randomized trial of continuous subcutaneous insulin infusion versus multiple daily insulin injection.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970964-8

7 January 2021

Continuous subcutaneous insulin infusion versus multiple daily injections: the impact of baseline A1c.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970964-8

7 January 2021

Continuous subcutaneous insulin infusion versus multiple daily injections: modeling predicted benefits in relationship to baseline A1c.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970964-8

7 January 2021

Reduction in severe hypoglycemia with long-term continuous subcutaneous insulin infusion in type I diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970964-8

7 January 2021

Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970964-8

7 January 2021

Determinants of glycaemic control in type 1 diabetes during intensified therapy with multiple daily insulin injections or continuous subcutaneous insulin infusion: importance of blood glucose variability

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970964-8

7 January 2021

In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970964-8

7 January 2021

A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970964-8

7 January 2021

Continuous subcutaneous insulin infusion (CSII) of insulin aspart versus multiple daily injection of insulin aspart/insulin glargine in type 1 diabetic patients previously treated with CSII.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970964-8

7 January 2021

Beneficial effects of continuous subcutaneous insulin infusion and flexible multiple daily insulin regimen using insulin glargine in type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970964-8

7 January 2021

An observational study comparing continuous subcutaneous insulin infusion (CSII) and insulin glargine in children with type 1 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970964-8

7 January 2021

Less severe hypoglycaemia, better metabolic control, and improved quality of life in Type 1 diabetes mellitus with continuous subcutaneous insulin infusion (CSII) therapy; an observational study of 100 consecutive patients followed for a mean of 2 y

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970964-8

7 January 2021

Insulin pump therapy in children and adolescents: improvements in key parameters of diabetes management including quality of life.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970964-8

7 January 2021

Investigation of quality of life and family burden issues during insulin pump therapy in children with Type 1 diabetes mellitus--a large-scale multicentre pilot study.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970964-8

7 January 2021

Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with diabetes mellitus: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970964-8

7 January 2021

Long-acting insulin analogs versus insulin pump therapy for the treatment of type 1 and type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970964-8

7 January 2021

Use of continuous subcutaneous insulin infusion pump in patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970964-8

7 January 2021

Treatment with intravenous insulin followed by continuous subcutaneous insulin infusion improves glycaemic control in severely resistant Type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970964-8

7 January 2021

The use of continuous insulin delivery systems in severely insulin-resistant patients

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970964-8

7 January 2021

Continuous subcutaneous insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetes: a randomized, parallel-group, 24-week study

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970964-8

7 January 2021

A clinical trial of continuous subcutaneous insulin infusion versus multiple daily injections in older adults with type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970964-8

7 January 2021

Insulin pump therapy vs. multiple daily injections in obese Type 2 diabetic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970964-8

7 January 2021

Effectiveness of intensive insulin therapy by multiple daily injections and continuous subcutaneous infusion: a comparison study in type 2 diabetes with conventional insulin regimen failure.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970964-8

7 January 2021

Efficacy of continuous subcutaneous insulin infusion in type 2 diabetes mellitus: a survey on a cohort of 102 patients with prolonged follow-up.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970964-8

7 January 2021

Long-term treatment combining continuous subcutaneous insulin infusion with oral hypoglycaemic agents is effective in type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970964-8

7 January 2021

10.1016/S1262-3636(11)70964-8

Identifiers

DOI

1 reference

26 August 2017

1 reference

PubMed ID

22208709